Serber Zachariah 4
4 · Zymergen Inc. · Filed Aug 15, 2022
Insider Transaction Report
Form 4
Serber Zachariah
DirectorChief Science Officer
Transactions
- Sale
Common Stock
2022-08-11$3.91/sh−5,435$21,251→ 2,554,953 total
Holdings
- 40,000(indirect: See Footnote)
Common Stock
- 40,000(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2021 that provides for the sale of up to 250,000 shares over the next ten (10) months, which started January 24, 2022.
- [F2]Held by the Rorik Serber 2021 Irrevocable Trust.
- [F3]Held by spouse as custodian for children under the California Uniform Transfer to Minors Act.